Da Costa R, Rooke J, Wells T, Cunningham A, Henderson I
NPJ Vaccines. 2024; 9(1):159.
PMID: 39218947
PMC: 11366766.
DOI: 10.1038/s41541-024-00953-6.
Ilinykh P, Huang K, Gunn B, Kuzmina N, Kedarinath K, Jurado-Cobena E
Commun Biol. 2024; 7(1):871.
PMID: 39020082
PMC: 11255267.
DOI: 10.1038/s42003-024-06556-0.
Xiao M, Ellsworth C, Qin X
Cell Mol Life Sci. 2024; 81(1):94.
PMID: 38368584
PMC: 10874912.
DOI: 10.1007/s00018-024-05157-8.
Abendstein L, Dijkstra D, Tjokrodirijo R, Van Veelen P, Trouw L, Hensbergen P
Nat Commun. 2023; 14(1):4027.
PMID: 37419978
PMC: 10328927.
DOI: 10.1038/s41467-023-39788-5.
Garcia-Alija M, Van Moer B, Sastre D, Azzam T, Du J, Trastoy B
Biotechnol Adv. 2023; 67:108201.
PMID: 37336296
PMC: 11027751.
DOI: 10.1016/j.biotechadv.2023.108201.
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants.
Fryer H, Hartley G, Edwards E, Varese N, Boo I, Bornheimer S
J Clin Immunol. 2023; 43(7):1506-1518.
PMID: 37322095
PMC: 10499924.
DOI: 10.1007/s10875-023-01527-2.
Avidity in antibody effector functions and biotherapeutic drug design.
Oostindie S, Lazar G, Schuurman J, Parren P
Nat Rev Drug Discov. 2022; 21(10):715-735.
PMID: 35790857
PMC: 9255845.
DOI: 10.1038/s41573-022-00501-8.
Communication pathways bridge local and global conformations in an IgG4 antibody.
Tarenzi T, Rigoli M, Potestio R
Sci Rep. 2021; 11(1):23197.
PMID: 34853348
PMC: 8636491.
DOI: 10.1038/s41598-021-02323-x.
Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement.
Vankemmelbeke M, McIntosh R, Chua J, Kirk T, Daniels I, Patsalidou M
Cancer Res. 2020; 80(16):3399-3412.
PMID: 32532823
PMC: 7611157.
DOI: 10.1158/0008-5472.CAN-19-3599.
Expanding the Scope of Antibody Rebridging with New Pyridazinedione-TCO Constructs.
Marquard A, Carlson J, Weissleder R
Bioconjug Chem. 2020; 31(6):1616-1623.
PMID: 32286045
PMC: 7788567.
DOI: 10.1021/acs.bioconjchem.0c00155.
Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility.
Liu X, Zhao Y, Shi H, Zhang Y, Yin X, Liu M
Nat Commun. 2019; 10(1):4206.
PMID: 31562320
PMC: 6765011.
DOI: 10.1038/s41467-019-12097-6.
The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.
Hui G, Gardener A, Begum H, Eldrid C, Thalassinos K, Gor J
J Biol Chem. 2019; 294(28):10789-10806.
PMID: 31088911
PMC: 6635440.
DOI: 10.1074/jbc.RA118.007134.
Heat-Killed , A Dectin-1 Agonist, Selectively Induces IgG4 Production by Human B Cells.
Park H, Yoon H, Kim J, Park S
Immune Netw. 2019; 18(6):e46.
PMID: 30619632
PMC: 6312892.
DOI: 10.4110/in.2018.18.e46.
CH2 Domain of Mouse IgG3 Governs Antibody Oligomerization, Increases Functional Affinity to Multivalent Antigens and Enhances Hemagglutination.
Klaus T, Bereta J
Front Immunol. 2018; 9:1096.
PMID: 29875771
PMC: 5974032.
DOI: 10.3389/fimmu.2018.01096.
Changes in N-glycans of IgG4 and its relationship with the existence of hypocomplementemia and individual organ involvement in patients with IgG4-related disease.
Konno N, Sugimoto M, Takagi T, Furuya M, Asano T, Sato S
PLoS One. 2018; 13(4):e0196163.
PMID: 29672582
PMC: 5908088.
DOI: 10.1371/journal.pone.0196163.
IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Typhimurium.
Zhang Y, Dominguez-Medina C, Cumley N, Heath J, Essex S, Bobat S
J Immunol. 2017; 199(12):4103-4109.
PMID: 29127147
PMC: 5713499.
DOI: 10.4049/jimmunol.1700952.
Investigating Structure and Dynamics of Proteins in Amorphous Phases Using Neutron Scattering.
Castellanos M, McAuley A, Curtis J
Comput Struct Biotechnol J. 2017; 15:117-130.
PMID: 28138368
PMC: 5257034.
DOI: 10.1016/j.csbj.2016.12.004.
Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.
Hocine H, Costa H, Dam N, Giustiniani J, Palacios I, Loiseau P
Sci Rep. 2017; 7:41125.
PMID: 28117403
PMC: 5259698.
DOI: 10.1038/srep41125.
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice.
Lo M, Kim H, Tong R, Bainbridge T, Vernes J, Zhang Y
J Biol Chem. 2017; 292(9):3900-3908.
PMID: 28077575
PMC: 5339770.
DOI: 10.1074/jbc.M116.767749.
Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation.
Valenzuela N, Hickey M, Reed E
Front Immunol. 2016; 7:433.
PMID: 27822209
PMC: 5075576.
DOI: 10.3389/fimmu.2016.00433.